Organogenesis Holdings (ORGO) Intangibles (2017 - 2026)
Organogenesis Holdings' (ORGO) quarterly Intangibles came in at $3.4 million in Q1 2026, down 70.44% year-on-year from $11.6 million in Q1 2025, and down 62.42% quarter-over-quarter from $9.1 million in Q4 2025.
Organogenesis Holdings (ORGO) Intangibles (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Intangibles history runs 10 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- On a quarterly basis, Intangibles fell 70.44% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 70.44% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, down 26.65% from the prior year.
- Intangibles eased to $3.4 million in Q1 2026 per ORGO's latest filing, from $9.1 million in the prior quarter.
- Across five years, Intangibles topped out at $24.5 million in Q1 2022 and bottomed at $3.4 million in Q1 2026.
- The 5-year median for Intangibles is $15.0 million (2024), against an average of $15.4 million.
- Across the five-year window, Intangibles fell 16.77% in 2022 and plunged 70.44% in 2026, its largest moves.
- Year by year, Intangibles stood at $20.8 million in 2022, then declined by 23.66% to $15.9 million in 2023, then fell by 21.44% to $12.5 million in 2024, then slipped by 26.65% to $9.1 million in 2025, then tumbled by 62.42% to $3.4 million in 2026.
- Per Business Quant, the three latest ORGO Intangibles figures stand at $3.4 million (Q1 2026), $9.1 million (Q4 2025), and $9.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | 3.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.44 Mn |
| Dec 31, 2025 | 9.15 Mn |
| Sep 30, 2025 | 9.94 Mn |
| Jun 30, 2025 | 10.79 Mn |
| Mar 31, 2025 | 11.63 Mn |
| Dec 31, 2024 | 12.47 Mn |
| Sep 30, 2024 | 13.30 Mn |
| Jun 30, 2024 | 14.14 Mn |
| Mar 31, 2024 | 14.97 Mn |
| Dec 31, 2023 | 15.87 Mn |
| Sep 30, 2023 | 17.10 Mn |
| Jun 30, 2023 | 18.33 Mn |
| Mar 31, 2023 | 19.56 Mn |
| Dec 31, 2022 | 20.79 Mn |
| Sep 30, 2022 | 22.01 Mn |
| Jun 30, 2022 | 23.23 Mn |
| Mar 31, 2022 | 24.45 Mn |
| Dec 31, 2021 | 25.67 Mn |
| Sep 30, 2021 | 26.90 Mn |
| Jun 30, 2021 | 28.14 Mn |